TY - JOUR
T1 - Weight lifting for women at risk for breast cancer-related lymphedema
T2 - A randomized trial
AU - Schmitz, Kathryn H.
AU - Ahmed, Rehana L.
AU - Troxel, Andrea B.
AU - Cheville, Andrea
AU - Lewis-Grant, Lorita
AU - Smith, Rebecca
AU - Bryan, Cathy J.
AU - Williams-Smith, Catherine T.
AU - Chittams, Jesse
PY - 2010
Y1 - 2010
N2 - Context Clinical guidelines for breast cancer survivors without lymphedema advise against upper body exercise, preventing them from obtaining established health benefits of weight lifting. Objective To evaluate lymphedema onset after a 1-year weight lifting intervention vs no exercise (control) among survivors at risk for breast cancer-related lymphedema (BCRL). Design, Setting, and Participants Arandomized controlled equivalence trial (Physical Activity andLymphedematrial) in the Philadelphia metropolitan area of154breast cancer survivors 1 to 5 years postunilateral breast cancer, with at least 2 lymphnodes removed and without clinical signs of BCRL at study entry. Participants were recruited between October 1, 2005, and February 2007, with data collection ending in August 2008. Intervention Weight lifting intervention included a gym membership and 13 weeks of supervised instruction, with the remaining 9 months unsupervised, vs no exercise. Main Outcome Measures Incident BCRL determined by increased arm swelling during 12 months (≥5% increase in interlimb difference). Clinician-defined BCRL onset was also evaluated. Equivalence margin was defined as doubling of lyphedema incidence. Results A total of 134 participants completed follow-up measures at 1 year. The proportion of women who experienced incident BCRL onset was 11% (8 of 72) in the weight lifting intervention group and 17% (13 of 75) in the control group (cumulative incidence difference [CID], ?6.0%; 95% confidence interval [CI], ?17.2% to 5.2%; P for equivalence=.04). Among women with 5 or more lymph nodes removed, the proportion who experienced incident BCRL onset was 7% (3 of 45) in the weight lifting intervention group and 22% (11 of 49) in the control group (CID, ?15.0%; 95% CI, ?18.6% to ?11.4%; P for equivalence=.003). Clinician-defined BCRL onset occurred in 1 woman in the weight lifting intervention group and 3 women in the control group (1.5% vs 4.4%, P for equivalence=.12). Conclusion In breast cancer survivors at risk for lymphedema, a program of slowly progressive weight lifting compared with no exercise did not result in increased incidence of lymphedema.
AB - Context Clinical guidelines for breast cancer survivors without lymphedema advise against upper body exercise, preventing them from obtaining established health benefits of weight lifting. Objective To evaluate lymphedema onset after a 1-year weight lifting intervention vs no exercise (control) among survivors at risk for breast cancer-related lymphedema (BCRL). Design, Setting, and Participants Arandomized controlled equivalence trial (Physical Activity andLymphedematrial) in the Philadelphia metropolitan area of154breast cancer survivors 1 to 5 years postunilateral breast cancer, with at least 2 lymphnodes removed and without clinical signs of BCRL at study entry. Participants were recruited between October 1, 2005, and February 2007, with data collection ending in August 2008. Intervention Weight lifting intervention included a gym membership and 13 weeks of supervised instruction, with the remaining 9 months unsupervised, vs no exercise. Main Outcome Measures Incident BCRL determined by increased arm swelling during 12 months (≥5% increase in interlimb difference). Clinician-defined BCRL onset was also evaluated. Equivalence margin was defined as doubling of lyphedema incidence. Results A total of 134 participants completed follow-up measures at 1 year. The proportion of women who experienced incident BCRL onset was 11% (8 of 72) in the weight lifting intervention group and 17% (13 of 75) in the control group (cumulative incidence difference [CID], ?6.0%; 95% confidence interval [CI], ?17.2% to 5.2%; P for equivalence=.04). Among women with 5 or more lymph nodes removed, the proportion who experienced incident BCRL onset was 7% (3 of 45) in the weight lifting intervention group and 22% (11 of 49) in the control group (CID, ?15.0%; 95% CI, ?18.6% to ?11.4%; P for equivalence=.003). Clinician-defined BCRL onset occurred in 1 woman in the weight lifting intervention group and 3 women in the control group (1.5% vs 4.4%, P for equivalence=.12). Conclusion In breast cancer survivors at risk for lymphedema, a program of slowly progressive weight lifting compared with no exercise did not result in increased incidence of lymphedema.
UR - http://www.scopus.com/inward/record.url?scp=78650427032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78650427032&partnerID=8YFLogxK
U2 - 10.1001/jama.2010.1837
DO - 10.1001/jama.2010.1837
M3 - Article
C2 - 21148134
AN - SCOPUS:78650427032
SN - 0098-7484
VL - 304
SP - 2699
EP - 2705
JO - JAMA
JF - JAMA
IS - 24
ER -